7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zhou QL et al. | Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. | 2016 | Mol Med Rep | pmid:27357904 |
| Cong Q et al. | p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. | 2016 | Stem Cell Reports | pmid:26947973 |
| Wang C et al. | Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. | 2016 | Med. Sci. Monit. | pmid:26939934 |
| Lin J et al. | Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. | 2016 | Nat Commun | pmid:26923114 |
| D'Abramo A et al. | Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. | 2016 | PLoS ONE | pmid:26913505 |
| Lu J et al. | Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. | 2016 | Exp. Biol. Med. (Maywood) | pmid:26908571 |
| Stuss M et al. | Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. | 2016 | Endokrynol Pol | pmid:26884284 |
| Gluba-Brzózka A et al. | Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. | 2016 | Lipids Health Dis | pmid:26843213 |
| Theodoro LH et al. | Effect of low-level laser therapy as an adjuvant in the treatment of periodontitis induced in rats subjected to 5-fluorouracil chemotherapy. | 2016 | J. Periodont. Res. | pmid:26750739 |
| Mitchell JA et al. | Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density. | 2016 | J. Bone Miner. Res. | pmid:26572781 |
| Liu G et al. | Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. | 2016 | Cell Tissue Res. | pmid:26004143 |
| Toffoli B et al. | Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. | 2016 | Mediators Inflamm. | pmid:28070143 |
| Chen H et al. | [Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. | 2016 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:28070039 |
| Shimazaki E et al. | TGF-β and Physiological Root Resorption of Deciduous Teeth. | 2016 | Int J Mol Sci | pmid:28035998 |
| Bolamperti S et al. | Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture. | 2016 | Biomed Res Int | pmid:27999816 |
| Zhao JJ et al. | MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. | 2016 | PLoS ONE | pmid:27459539 |
| Ugay L et al. | Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. | 2016 | Chin. Med. J. | pmid:27411457 |
| Pellegrini GG et al. | Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. | 2016 | Nutrients | pmid:27409635 |
| Nagy EE et al. | High circulating osteoprotegerin levels are associated with non-zero blood groups. | 2016 | BMC Cardiovasc Disord | pmid:27387019 |
| Zhang YY et al. | Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. | 2016 | Chin J Dent Res | pmid:27379348 |
| Songia P et al. | Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. | 2016 | J. Mol. Cell. Cardiol. | pmid:27338002 |
| Li Y et al. | OPG and RANKL polymorphisms are associated with alcohol-induced osteonecrosis of the femoral head in the north area of China population in men. | 2016 | Medicine (Baltimore) | pmid:27336899 |
| Dolan EB et al. | Thermally induced osteocyte damage initiates pro-osteoclastogenic gene expression in vivo. | 2016 | J R Soc Interface | pmid:27335224 |
| Sasso GR et al. | Elevated serum osteoprotegerin levels in women: friend or foe? | 2015 Nov-Dec | Rev Assoc Med Bras (1992) | pmid:26841162 |
| Calasans-Maia MD et al. | Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814461 |
| Jianru YI et al. | Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814456 |
| SaÄŸlam M et al. | Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. | 2015 Jan-Feb | J Appl Oral Sci | pmid:25760266 |
| Esteghamati A et al. | Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. | 2015 Aug-Sep | Arch Cardiovasc Dis | pmid:26184866 |
| Li B et al. | Expression of OPG, RANKL, and RUNX2 in rabbit periodontium under orthodontic force. | 2015 | Genet. Mol. Res. | pmid:26782591 |
| Rewiuk K and Grodzicki T | Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. | 2015 | Biomed Res Int | pmid:26504794 |
| Pesce Viglietti AI et al. | Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion. | 2015 | Infect. Immun. | pmid:26459511 |
| Nemeth ZK et al. | Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. | 2015 | Sci Rep | pmid:26459001 |
| Zhang HL and Jin X | Relationship between serum adiponectin and osteoprotegerin levels and coronary heart disease severity. | 2015 | Genet. Mol. Res. | pmid:26400332 |
| Pitari MR et al. | Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. | 2015 | Oncotarget | pmid:26160841 |
| Hsu BG et al. | High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. | 2015 | Tohoku J. Exp. Med. | pmid:26156285 |
| Miao X et al. | Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma. | 2015 | J Orthop Surg Res | pmid:26148858 |
| Bartosińska J et al. | The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. | 2015 | Mediators Inflamm. | pmid:26146462 |
| Ye XH et al. | Osteoprotegerin polymorphisms in Chinese Han patients with rheumatoid arthritis. | 2015 | Genet. Mol. Res. | pmid:26125863 |
| Yu SG et al. | Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice. | 2015 | Int J Clin Exp Pathol | pmid:26097549 |
| Su F et al. | Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. | 2015 | Stem Cell Res Ther | pmid:25888745 |
| Shen Y et al. | (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. | 2015 | BMC Complement Altern Med | pmid:25887296 |
| Duan P et al. | Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. | 2015 | BMC Womens Health | pmid:25884698 |
| Warren JT et al. | Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function. | 2015 | J. Cell. Biochem. | pmid:25864714 |
| Kim KR et al. | 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. | 2015 | PLoS ONE | pmid:25859665 |
| Wu C et al. | Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. | 2015 | Genes Dev. | pmid:25846796 |
| Oostra DR et al. | Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. | 2015 | Mol. Cell. Endocrinol. | pmid:25575458 |
| Majerczyk M et al. | [Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. | 2015 | Postepy Hig Med Dosw (Online) | pmid:27259222 |
| Fu Y et al. | Involvement of the Ca²⺠signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. | 2015 | J. Vet. Sci. | pmid:25549213 |
| Lin TH et al. | NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. | 2015 | Tissue Eng Part A | pmid:25518013 |
| Meijome TE et al. | GATA-1 deficiency rescues trabecular but not cortical bone in OPG deficient mice. | 2015 | J. Cell. Physiol. | pmid:25205203 |